Cellexus Biosystems Appoints First International Distributors And Announces Exhibition Schedule For 2007
Cellexus Biosystems PLC of Cambridgeshire, UK, announces the appointment of its first international distributors. The Company also reveals its global exhibition schedule for 2007, part of a programme by which it will present a stream of new products to its customers throughout next year.
Cellexus Biosystems has appointed the following organisations as its distributors and providers of front-line support:
- Australia: John Morris Scientific Pty Ltd
- France: Proteigene
- Israel: GoldiScience Ltd
- Singapore: Continental Lab Products Pte Ltd
- South Korea: Kyongshin Scientific Co., Ltd.
"We are very pleased to be working with a group of such highly professional and successful distributors" stated Dr Kevin Auton (CEO). We look forward to a productive and successful partnership with our first distributors and we will be appointing further distributors in the coming months."
Separately, the Company also unveiled its schedule of attendance at exhibitions planned for 2007. These follow on from successful exhibitions at ComBio2006 (Brisbane Australia) and Pabord 2006 (London, United Kingdom). The Company's conference schedule for 2007 includes over 11 events:
- Antibody Development & Production (Carlsbad, USA) 1st - 3rd March, 2007
- BioProcess International (Paris, France) 24th - 25th April 2007
- BIO 2007 (Boston, USA) 6th – 9th May 2007
- PEGS, Protein Engineering Summit (Boston, USA) 14th -18th May 2007
- ESACT 2007 (Dresden, Germany) 17th – 20th June 2007
- Disposables For Biopharma Manufacturing (USA) June 2007
Cellexus Biosystems appoints first international distributors and announces exhibition schedule for 2007 / page 2
- 6th International BioForum & BioExpo Japan (Tokyo, Japan) 20th – 22nd June 2007
- CELLutions Summit (Boston, USA) 20th – 23rd August 2007
- BioProduction, (Europe) 22nd – 23rd October 2007
- BioProcess International (Boston, USA) 30th Sept – 4th October 2007
- BioPharm Manufacturing (USA) December 2007
Conferences being attended in 2006 also include: BioProduction in October (Dublin, Ireland) and BioProcess in November (San Francisco, United States of America).
"Attending these events is an important objective for Cellexus Biosystems. It is a way of connecting with leading researchers and production scientists from around the World and represents an excellent way of demonstrating to our customers how our technology can offer performance and cost-saving benefits" explained Dr Auton. "The CellMaker Lite is a simple but revolutionary product. The best way to understand how it works is to see it first hand and operate it at these events."
The Company plans to launch each of its new products at these events, during the remaining part of 2006 and throughout 2007. The Directors of the issuer accept responsibility for this announcement.
SOURCE: Cellexus Biosystems PLC